Most cancers arise from abnormal genes or gene regulation. These abnormalities can occur through inheritance, from environmental insults, or via random mutation. The genetic changes that allow tumors to grow and spread differ between individuals even when they have the same cancer type and stage. Therefore, two people with the same cancer type given the same therapeutic may respond differently based on their cancer’s genetics. Precision medicine allows more targeted therapies, leveraging genetic information about tumor pathogenesis. The precision medicine approach, however, is not yet part of routine care for most cancer patients. To explore where precision oncology is currently positioned in cancer therapy, and to discuss where it could be going, The Scientist is bringing together a panel of experts in the field for this free educational webinar.
Topics to be covered:
- How to Make Precision...
Meet the Speakers:
Sofia Merajver, MD, PhD
Professor, Epidemiology, and Dept. of Internal Medicine
Director, Breast and Ovarian Cancer Risk and Evaluation Program
University of Michigan, School of Public Health
India Hook-Barnard, PhD
Director of Research Strategy
Associate Director, UCSF Precision Medicine
University of California, San Francisco